During the past decade, Sejong General Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 4 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sejong General Hospital" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Duk-Woo Park, MD" with 3 trials sponsored, "Samsung Medical Center" with 3 trials sponsored and "Seung-Jung Park" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sejong General Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 5 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Sejong General Hospital" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Sejong General Hospital" are "Atrial Fibrillation" (7 trials), "Coronary Artery Disease" (5 trials), "Heart Failure" (4 trials), "Aortic Valve Disease" (2 trials) and "Aortic Valve Stenosis" (2 trials). Many other conditions were trialed in "Sejong General Hospital" in a lesser frequency.

Most popular intervention types in "Sejong General Hospital" are "Device" (21 trials), "Drug" (10 trials), "Procedure" (5 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Udenafil" (2 trials), "Additional posterior wall isolation" (1 trials), "Alpine" (1 trials) and "Arm 1 (ATP+Shock)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sejong General Hospital" are 40 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sejong General Hospital". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Sejong General Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sejong General Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 12 trials that are defined as “Not Applicable".